Epidemiology of lymphogranuloma venereum in New South Wales, 2006-2015

• Published in: Communicable diseases intelligence (2018) Vol. 43
• Main Authors: Kotevski, Damian P, Lam, Meeyin, Selvey, Christine E, Templeton, David J, Donovan, Linda G, Sheppeard, Vicky
• Format: Journal Article
• Language: English
• Published: Australia 18.11.2019
• Subjects: Adolescent; Adult; Aged; Chlamydia trachomatis - isolation & purification; Disease Notification; Epidemiological Monitoring; Homosexuality, Male; Humans; Lymphogranuloma Venereum - epidemiology; Lymphogranuloma Venereum - microbiology; Male; Middle Aged; New South Wales - epidemiology; Rectal Diseases; Sexual and Gender Minorities; Young Adult; New South Wales; epidemiology; New South Wales; sexually transmissible infections; gay and bisexual men; Chlamydia trachomatis; lymphogranuloma venereum; surveillance
• ISSN: 2209-6051
• DOI: 10.33321/cdi.2019.43.54

To describe the epidemiology of lymphogranuloma venereum (LGV) in New South Wales (NSW) from 2006 to 2015. LGV notification data between 2006 and 2015 from New South Wales were analysed to describe time trends in counts and rates by gender, age group and area of residence, as well as anatomical sites of infection. A positivity ratio was calculated using the number of LGV notifications per 100 anorectal chlamydia notifications per year. Data linkage was used to ascertain the proportion of LGV cases that were co-infected with HIV. There were 208 notifications of LGV in NSW from 2006 to 2015; all were among men, with a median age of 42 years, and half were residents of inner-city Sydney. Annual notifications peaked at 57 (1.6 per 100,000 males) in 2010, declined to 16 (0.4 per 100,000 males) in 2014, and then increased to 34 (0.9 per 100,000 males) in 2015. Just under half (47.4%) of LGV cases were determined to be co-infected with HIV. The number of LGV notifications each year has not returned to the low levels seen prior to the peak in 2010. Continued public health surveillance is important for the management and control of LGV.